Cargando…

MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer

Advanced pancreatic cancer is characterized by few treatment options and poor outcomes. Oncolytic virotherapy and chemotherapy involve complementary pharmacodynamics and could synergize to improve therapeutic efficacy. Likewise, multimodality treatment may cause additional toxicity, and new agents h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Hans Martin, Leber, Mathias Felix, Bossow, Sascha, Engeland, Christine E., Dessila, Jan, Grossardt, Christian, Zaoui, Karim, Bell, John C., Jäger, Dirk, von Kalle, Christof, Ungerechts, Guy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182383/ https://www.ncbi.nlm.nih.gov/pubmed/34141871 http://dx.doi.org/10.1016/j.omto.2021.04.015

Ejemplares similares

Oncolytic Measles Virus Encoding MicroRNA for Targeted RNA Interference †
por: Anker, Sophie C., et al.
Publicado: (2023)

Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites
por: Leber, Mathias Felix, et al.
Publicado: (2018)

Measles Virus as an Oncolytic Immunotherapy
por: Engeland, Christine E., et al.
Publicado: (2021)

Engineering and combining oncolytic measles virus for cancer therapy
por: Leber, Mathias F., et al.
Publicado: (2020)

Chemovirotherapy: combining chemotherapeutic treatment with oncolytic virotherapy
por: Binz, Eike, et al.
Publicado: (2015)

Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses
por: Ungerechts, Guy, et al.
Publicado: (2016)

Chemovirotherapy of Lung Squamous Cell Carcinoma by Combining Oncolytic Adenovirus With Gemcitabine
por: Liu, Xing, et al.
Publicado: (2020)

Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory
por: Veinalde, Rūta, et al.
Publicado: (2021)

Immunological Effects and Viral Gene Expression Determine the Efficacy of Oncolytic Measles Vaccines Encoding IL-12 or IL-15 Agonists
por: Backhaus, Paul S., et al.
Publicado: (2019)

Chemovirotherapy of Pancreatic Adenocarcinoma by Combining Oncolytic Vaccinia Virus GLV-1h68 with nab-Paclitaxel Plus Gemcitabine
por: Binz, Eike, et al.
Publicado: (2017)

Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine
por: Engeland, Christine E.
Publicado: (2022)

Mathematical Analysis of a Mathematical Model of Chemovirotherapy: Effect of Drug Infusion Method
por: Malinzi, Joseph
Publicado: (2019)

Viro-antibody therapy: engineering oncolytic viruses for genetic delivery of diverse antibody-based biotherapeutics
por: Kontermann, Roland E., et al.
Publicado: (2021)

Measles Vaccines Designed for Enhanced CD8(+) T Cell Activation
por: Busch, Elena, et al.
Publicado: (2020)

Lighting a Fire in the Tumor Microenvironment Using Oncolytic Immunotherapy
por: Achard, Carole, et al.
Publicado: (2018)

Measles to the Rescue: A Review of Oncolytic Measles Virus
por: Aref, Sarah, et al.
Publicado: (2016)

Measles virus: Background and oncolytic virotherapy
por: Bhattacharjee, Sankhajit, et al.
Publicado: (2018)

Advances in oncolytic virotherapy
por: Russell, Stephen J., et al.
Publicado: (2022)

Advances in the design and development of oncolytic measles viruses
por: Hutzen, Brian, et al.
Publicado: (2015)

Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics
por: Ungerechts, Guy, et al.
Publicado: (2010)

In Vivo Imaging of Oncolytic Measles Virus Propagation with Single-Cell Resolution
por: Kemler, Iris, et al.
Publicado: (2018)

Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine Virus
por: Scheubeck, Gabriel, et al.
Publicado: (2019)

A Combined Ultrafiltration/Diafiltration Process for the Purification of Oncolytic Measles Virus
por: Loewe, Daniel, et al.
Publicado: (2022)

MicroRNA-Mediated Suppression of Oncolytic Adenovirus Replication in Human Liver
por: Ylösmäki, Erkko, et al.
Publicado: (2013)

Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin
por: Hutzen, Brian, et al.
Publicado: (2014)

Cap-dependent translational control of oncolytic measles virus infection in malignant mesothelioma
por: Jacobson, Blake A., et al.
Publicado: (2017)

Aeration and Shear Stress Are Critical Process Parameters for the Production of Oncolytic Measles Virus
por: Grein, Tanja A., et al.
Publicado: (2019)

Graphene oxide arms oncolytic measles virus for improved effectiveness of cancer therapy
por: Xia, Mao, et al.
Publicado: (2019)

MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum
por: Muñoz-Alía, Miguel Ángel, et al.
Publicado: (2021)

Oncolytic Rodent Protoparvoviruses Evade a TLR- and RLR-Independent Antiviral Response in Transformed Cells
por: Angelova, Assia, et al.
Publicado: (2023)

Development of measles virus-based shielded oncolytic vectors: suitability of other paramyxovirus glycoproteins
por: Hudacek, Andrew W., et al.
Publicado: (2013)

Attenuated measles virus used as an oncolytic virus activates myeloid and plasmacytoid dendritic cells
por: Fonteneau, Jean-François, et al.
Publicado: (2013)

Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy
por: Iankov, Ianko D., et al.
Publicado: (2015)

Measles Edmonston Vaccine Strain Derivatives have Potent Oncolytic Activity against Osteosarcoma
por: Musibay, Evidio Domingo, et al.
Publicado: (2014)

Using Cystine Knot Proteins as a Novel Approach to Retarget Oncolytic Measles Virus
por: Lal, Sangeet, et al.
Publicado: (2017)

Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers
por: Nagalo, Bolni Marius, et al.
Publicado: (2020)

Implications of MicroRNAs in Oncolytic Virotherapy
por: Bofill-De Ros, Xavier, et al.
Publicado: (2017)

Natural Oncolytic Activity of Live-Attenuated Measles Virus against Human Lung and Colorectal Adenocarcinomas
por: Boisgerault, Nicolas, et al.
Publicado: (2013)

Oncolytic measles virus strains have significant antitumor activity against glioma stem cells
por: Allen, Cory, et al.
Publicado: (2012)

Proof-of-principle that a decoy virus protects oncolytic measles virus against neutralizing antibodies
por: Xu, Chun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qp5l0i8mu4a8j7m98ua73mjl4n